Luye Pharma's Shandong Boan Bio Reports 17.5% Revenue Growth in 2024
Company

Luye Pharma’s Shandong Boan Bio Reports 17.5% Revenue Growth in 2024

MicroPort CardioFlow Medtech Reports 7.5% Revenue Growth in 2024 Driven by Global Expansion
Company

MicroPort CardioFlow Medtech Reports 7.5% Revenue Growth in 2024 Driven by Global Expansion

Hengrui Pharmaceuticals Gets NMPA Green Light for HRS-1738 and HRS-5817 Clinical Trials
CompanyDrug

Hengrui Pharmaceuticals Gets NMPA Green Light for HRS-1738 and HRS-5817 Clinical Trials

MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots
Company

MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots

Sanofi's mRNA Chlamydia Vaccine Gains FDA Fast Track Designation
CompanyDrug

Sanofi’s mRNA Chlamydia Vaccine Gains FDA Fast Track Designation

Fangzhou Inc. Partners with Tencent Health to Advance AI-Driven Healthcare Solutions
CompanyDeals

Fangzhou Inc. Partners with Tencent Health to Advance AI-Driven Healthcare Solutions

Merck, Sharp & Dohme's Capvaxive Approved by European Commission for Pneumococcal Prevention
CompanyDrug

Merck, Sharp & Dohme’s Capvaxive Approved by European Commission for Pneumococcal Prevention

Jiangsu Hengrui Pharmaceuticals Receives NMPA Approval for SHR-9803 and SHR-A2102 Clinical Trials
CompanyDrug

Jiangsu Hengrui Pharmaceuticals Receives NMPA Approval for SHR-9803 and SHR-A2102 Clinical Trials

Servier and Black Diamond Therapeutics Ink Global Deal for Solid Tumor Targeted Therapy BDTX-4933
CompanyDeals

Servier and Black Diamond Therapeutics Ink Global Deal for Solid Tumor Targeted Therapy BDTX-4933

Bio-Thera Solutions Inks Licensing Deal with Dr. Reddy’s for Biosimilar Commercialization
CompanyDeals

Bio-Thera Solutions Inks Licensing Deal with Dr. Reddy’s for Biosimilar Commercialization

Shanghai Junshi Biosciences' Loqtorzi Approved in Singapore for Nasopharyngeal Carcinoma
CompanyDrug

Shanghai Junshi Biosciences’ Loqtorzi Approved in Singapore for Nasopharyngeal Carcinoma

Zhejiang Funuo Medicine Launches Triple Cream for Melasma Treatment in China
CompanyDrug

Zhejiang Funow Medicine Launches Triple Cream for Melasma Treatment in China